Asthma
Current Care Summary |  Published: 2013-02-20  
Working group appointed by the Finnish Medical Society Duodecim, the Finnish Respiratory Society, the Finnish Paediatric Society and the Finnish Society of Clinical Physiology
Print

Asthma

Current Care Summary
20.2.2013
Working group appointed by the Finnish Medical Society Duodecim, the Finnish Respiratory Society, the Finnish Paediatric Society and the Finnish Society of Clinical Physiology

Current Care Guideline «Astma»1 and Summary in Finnish «Astma»2

Asthma is an inflammatory disease of the lower airways. The typical symptoms of asthma are cough, wheezing and shortness of breath. Asthma is diagnosed based on measures of pulmonary function showing variable or reversible airways obstruction. The basic pharmacological treatment consists of alleviating the asthmatic inflammation with regular inhaled glucocorticoids and relieving sudden obstructions with as-needed inhaled beta2-agonists. The treatment is adjusted based on asthma control. If good control of asthma is not achieved with low to medium doses of inhaled glucocorticoids, additional control medication (inhaled long acting beta2-agonists, antileukotrienes, in adults also theophylline or tiotrohium) should be introduced.

Tari Haahtela

Lauri Lehtimäki

Eeva Ahonen

Terttu Harju

Tuomas Jartti

Hannu Kankaanranta

Krista Korhonen

Mika Mäkelä

Marja Puurunen

Anssi Sovijärvi

Erkka Valovirta

Kari KK Venho

Current Care Guidelines are independent, evidence-based clinical practice guidelines. These national guidelines cover important issues related to Finnish health, medical treatment as well as prevention of diseases. Learn more